Pathogen reduction using riboflavin and UV light (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pathogen reduction using riboflavin and UV light" in English language version.

refsWebsite

Global rank English rank

8doi.org

2^nd place

8nih.gov

4^th place

4semanticscholar.org

11^th place

8^th place

1worldcat.org

5^th place

1handle.net

102^nd place

76^th place

1zenodo.org

621^st place

380^th place

1caridianbct.com

low place

1businesswire.com

615^th place

407^th place

1allbusiness.com

2,914^th place

1,755^th place

1healthcaretechnologyonline.com

low place

allbusiness.com

All Business. (2008, October 6). Warsaw Blood Center Selects CaridianBCT for Mirasol PRT. [Press Release]. Retrieved from http://www.allbusiness.com/medicine-health/public-health-blood-supply-donations/11595632-1.html

businesswire.com

Business Wire. (2010, July 20). Belgian Red Cross-Flanders Selects CaridianBCT’s Mirasol® Pathogen Reduction Technology System. [Press Release]. Retrieved from http://www.businesswire.com/news/home/20100720007038/en/Belgian-Red-Cross-Flanders-Selects-CaridianBCT%E2%80%99s-Mirasol%C2%AE-Pathogen

caridianbct.com

CaridianBCT. (2010, June 23). CaridianBCT’s Mirasol Pathogen Reduction Technologies System Selected to Increase Safety of Poland’s Blood Supply. [Press Release]. Retrieved from http://www.caridianbct.com/location/north-america/about-caridianbct/press-room/Pages/23JUN,2010-CaridianBCTMirasolPathogenReductionTechnologiesSystemSelectedtoIncreaseSafetyofPoland%E2%80%99sBloodSupply.aspx

doi.org

Hardwick CC, Herivel TR, Hernandez SC, Ruane PH, Goodrich RP (2004). "Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology". Photochem. Photobiol. 80 (3): 609–15. doi:10.1562/0031-8655(2004)080<0609:TNSIAQ>2.0.CO;2. ISSN 0031-8655. PMID 15382964. S2CID 198154059.
Sullivan J, et al. (2008). "Pathogen Inactivation of plasmodium Falciparum in Plasma and Platelet Concentrations with Riboflavin and UV Light". Vox Sanguinis. 95 (Suppl. 1): 278–279. doi:10.1111/j.1423-0410.2008.01056.x. hdl:10292/2147.
Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP (April 2008). "Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation". Transfus Med Rev. 22 (2): 133–53. doi:10.1016/j.tmrv.2007.12.003. PMID 18353253.
Larrea L, Calabuig M, Roldán V, Rivera J, Tsai HM, Vicente V, Roig R (December 2009). "The influence of riboflavin photochemistry on plasma coagulation factors". Transfus. Apher. Sci. 41 (3): 199–204. doi:10.1016/j.transci.2009.09.006. PMC 3158998. PMID 19782644.
Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP (June 2004). "Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light". Transfusion. 44 (6): 877–85. doi:10.1111/j.1537-2995.2004.03355.x. PMID 15157255. S2CID 24109912.
Fast LD, Dileone G, Marschner S (December 2010). "Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation". Transfusion. 51 (7): 1397–1404. doi:10.1111/j.1537-2995.2010.02984.x. PMID 21155832. S2CID 34154946.
Goodrich RP, Custer B, Keil S, Busch M (August 2010). "Defining "adequate" pathogen reduction performance for transfused blood components". Transfusion. 50 (8): 1827–37. doi:10.1111/j.1537-2995.2010.02635.x. PMID 20374558. S2CID 11538115.
Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R (October 2007). "Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light". Transfus. Apher. Sci. 37 (2): 131–7. doi:10.1016/j.transci.2007.07.002. PMID 17950672.

handle.net

hdl.handle.net

Sullivan J, et al. (2008). "Pathogen Inactivation of plasmodium Falciparum in Plasma and Platelet Concentrations with Riboflavin and UV Light". Vox Sanguinis. 95 (Suppl. 1): 278–279. doi:10.1111/j.1423-0410.2008.01056.x. hdl:10292/2147.

healthcaretechnologyonline.com

Healthcare Technology Online. (2008, August 6). CaridianBCT Receives CE Mark for Mirasol Pathogen Reduction Technology System for Plasma. [Press Release]. Retrieved from http://www.healthcaretechnologyonline.com/article.mvc/CaridianBCT-Receives-CE-Mark-For-Mirasol-0001?VNETCOOKIE=NO

nih.gov

pubmed.ncbi.nlm.nih.gov

Hardwick CC, Herivel TR, Hernandez SC, Ruane PH, Goodrich RP (2004). "Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology". Photochem. Photobiol. 80 (3): 609–15. doi:10.1562/0031-8655(2004)080<0609:TNSIAQ>2.0.CO;2. ISSN 0031-8655. PMID 15382964. S2CID 198154059.
Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP (April 2008). "Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation". Transfus Med Rev. 22 (2): 133–53. doi:10.1016/j.tmrv.2007.12.003. PMID 18353253.
Larrea L, Calabuig M, Roldán V, Rivera J, Tsai HM, Vicente V, Roig R (December 2009). "The influence of riboflavin photochemistry on plasma coagulation factors". Transfus. Apher. Sci. 41 (3): 199–204. doi:10.1016/j.transci.2009.09.006. PMC 3158998. PMID 19782644.
Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP (June 2004). "Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light". Transfusion. 44 (6): 877–85. doi:10.1111/j.1537-2995.2004.03355.x. PMID 15157255. S2CID 24109912.
Fast LD, Dileone G, Marschner S (December 2010). "Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation". Transfusion. 51 (7): 1397–1404. doi:10.1111/j.1537-2995.2010.02984.x. PMID 21155832. S2CID 34154946.
Goodrich RP, Custer B, Keil S, Busch M (August 2010). "Defining "adequate" pathogen reduction performance for transfused blood components". Transfusion. 50 (8): 1827–37. doi:10.1111/j.1537-2995.2010.02635.x. PMID 20374558. S2CID 11538115.
Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R (October 2007). "Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light". Transfus. Apher. Sci. 37 (2): 131–7. doi:10.1016/j.transci.2007.07.002. PMID 17950672.

ncbi.nlm.nih.gov

Larrea L, Calabuig M, Roldán V, Rivera J, Tsai HM, Vicente V, Roig R (December 2009). "The influence of riboflavin photochemistry on plasma coagulation factors". Transfus. Apher. Sci. 41 (3): 199–204. doi:10.1016/j.transci.2009.09.006. PMC 3158998. PMID 19782644.

semanticscholar.org

api.semanticscholar.org

Hardwick CC, Herivel TR, Hernandez SC, Ruane PH, Goodrich RP (2004). "Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology". Photochem. Photobiol. 80 (3): 609–15. doi:10.1562/0031-8655(2004)080<0609:TNSIAQ>2.0.CO;2. ISSN 0031-8655. PMID 15382964. S2CID 198154059.
Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP (June 2004). "Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light". Transfusion. 44 (6): 877–85. doi:10.1111/j.1537-2995.2004.03355.x. PMID 15157255. S2CID 24109912.
Fast LD, Dileone G, Marschner S (December 2010). "Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation". Transfusion. 51 (7): 1397–1404. doi:10.1111/j.1537-2995.2010.02984.x. PMID 21155832. S2CID 34154946.
Goodrich RP, Custer B, Keil S, Busch M (August 2010). "Defining "adequate" pathogen reduction performance for transfused blood components". Transfusion. 50 (8): 1827–37. doi:10.1111/j.1537-2995.2010.02635.x. PMID 20374558. S2CID 11538115.

worldcat.org

Hardwick CC, Herivel TR, Hernandez SC, Ruane PH, Goodrich RP (2004). "Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology". Photochem. Photobiol. 80 (3): 609–15. doi:10.1562/0031-8655(2004)080<0609:TNSIAQ>2.0.CO;2. ISSN 0031-8655. PMID 15382964. S2CID 198154059.

zenodo.org

Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R (October 2007). "Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light". Transfus. Apher. Sci. 37 (2): 131–7. doi:10.1016/j.transci.2007.07.002. PMID 17950672.